| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |